| | | | | | | | | | | | | | | | |
| |
| Issue Date FY: 2024 ( Subtotal = $75,508,038 ) (Continued on the next page) |
| 2024 | 2024 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01AI141787 | Local immune tolerance in the large intestine mediated by GPR15 | 001 | 5 | NIH | 5/24/2024 | $54,699 |
| 2024 | 2024 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01AI141787 | Local immune tolerance in the large intestine mediated by GPR15 | 000 | 5 | NIH | 1/26/2024 | $492,284 |
| 2024 | 2024 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | UH3CA247605 | Quantitative Lung Function Imaging to Reduce Toxicity for patients treated with Radiation and Immunotherapy | 001 | 4 | NIH | 9/9/2024 | $223,430 |
| 2024 | 2024 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01AR082944 | The role of collagen VII in extracellular matrix protein secretion | 000 | 1 | NIH | 5/31/2024 | $343,200 |
| 2024 | 2024 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R21AR084212 | Gene Therapy for PXE: Breaking the Barrier of Ectopic Calcification | 000 | 1 | NIH | 5/2/2024 | $171,600 |
| 2024 | 2024 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R35GM152198 | Novel Mechanisms and Regulation of Mammalian Double-Strand Break Repair | 000 | 1 | NIH | 1/1/2024 | $629,912 |
| 2024 | 2024 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R03CA292985 | Circulating tumor cell profiling for genomic contributors to racial disparity in metastatic prostate cancer | 000 | 1 | NIH | 7/12/2024 | $156,000 |
| 2024 | 2024 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R21EY035462 | Investigating the role of mitochondrial function in driving lens fibrotic disease | 000 | 1 | NIH | 5/30/2024 | $429,000 |
| 2024 | 2024 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | T5C52049 | Primary Care Training and Enhancement - Language and Disability Access | 01 | 2 | HRSA | 7/18/2024 | $5,356 |
| 2024 | 2024 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | T5C52049 | Primary Care Training and Enhancement - Language and Disability Access | 02 | 2 | HRSA | 8/19/2024 | $2,777 |
| 2024 | 2024 | THOMAS JEFFERSON UNIVERSITY | 833 Chestnut St | Philadelphia | PA | 19107-4427 | PHILADELPHIA | USA | T5C52049 | Primary Care Training and Enhancement - Language and Disability Access | 00 | 2 | HRSA | 5/29/2024 | $594,183 |
| 2024 | 2024 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01NS121143 | Developing RNA Oligonucleotides to Mitigate Abberant FUS Phase Transition in FTD/ALS | 001 | 2 | NIH | 8/13/2024 | $379,538 |
| 2024 | 2024 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01NS121143 | Developing RNA Oligonucleotides to Mitigate Abberant FUS Phase Transition in FTD/ALS | 000 | 2 | NIH | 4/16/2024 | $390,000 |
| 2024 | 2024 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01DK138834 | Targeting visceral pain through intestinal neuropod cell GUCY2C signaling | 000 | 2 | NIH | 7/15/2024 | $654,052 |
| 2024 | 2024 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01HL173113 | Allosteric modulation of beta2- adrenoceptors in the treatment of asthma | 001 | 1 | NIH | 6/14/2024 | $56,650 |
| 2024 | 2024 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | T32GM008562 | Clinical Pharmacology Training Program | 001 | 30 | NIH | 8/20/2024 | $222,046 |
| 2024 | 2024 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R37NS108114 | The role of the AR interactome in SBMA | 001 | 6 | NIH | 8/12/2024 | $2,049 |
| 2024 | 2024 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01HL058506 | G Protein-Coupled Receptor Regulation in Airway Myocytes | 003 | 25 | NIH | 9/18/2024 | $572,142 |
| 2024 | 2024 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R35GM131832 | Molecular Mechanisms of Mitochondrial Transcription and Replication | 000 | 6 | NIH | 7/4/2024 | $544,190 |
| 2024 | 2024 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R37NS108114 | The role of the AR interactome in SBMA | 000 | 6 | NIH | 5/14/2024 | $704,752 |
| 2024 | 2024 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | S10OD036371 | A multiplex automatic autostainer at Jefferson | 000 | 1 | NIH | 8/28/2024 | $195,000 |
| 2024 | 2024 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01CA266592 | The Role of IL-15 in Cutaneous T-cell Lymphoma Progression | 000 | 2 | NIH | 7/15/2024 | $339,008 |
| 2024 | 2024 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R21MH135361 | Cell type specific analysis of Src kinase-NMDA receptor complexes in schizophrenia | 000 | 1 | NIH | 7/3/2024 | $429,000 |
| 2024 | 2024 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01HL164941 | Crosstalk Ca2+ Signaling between Ryanodine Receptors Type 1 and 2 in the Pathogenesis of Cardiac Hypertrophy and Heart Failure | 001 | 2 | NIH | 6/20/2024 | $45,475 |
| 2024 | 2024 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01DK136992 | Hypercalciuria and Abnormal Bone in the Genetic Hypercalciuric Stone-Forming Rats | 000 | 1 | NIH | 3/19/2024 | $430,626 |
| 2024 | 2024 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R21DE033558 | Targeting miRNA-loaded exosomes to HNSCC with Dsg2-directed scFv fusion proteins | 000 | 1 | NIH | 9/10/2024 | $429,000 |
| 2024 | 2024 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01AI155666 | miR-21 regulation of autoreactive B cell and lupus nephritis development | 000 | 3 | NIH | 7/16/2024 | $537,976 |
| 2024 | 2024 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R21AI182763 | The role of CXCL10 expressing B cells in skin inflammation | 000 | 1 | NIH | 6/6/2024 | $175,500 |
| 2024 | 2024 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01HL164941 | Crosstalk Ca2+ Signaling between Ryanodine Receptors Type 1 and 2 in the Pathogenesis of Cardiac Hypertrophy and Heart Failure | 000 | 2 | NIH | 3/8/2024 | $511,596 |
| 2024 | 2024 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R21AI182763 | The role of CXCL10 expressing B cells in skin inflammation | 001 | 1 | NIH | 9/11/2024 | $19,500 |
| 2024 | 2024 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01CA238241 | Microbubble Cavitation for Improving Hepatocellular Carcinoma Radioembolization | 001 | 5 | NIH | 4/17/2024 | $16,811 |
| 2024 | 2024 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01DK138011 | Relevance of fatty acid handling in the adaptive response to mitochondrial dysfunction | 001 | 1 | NIH | 5/1/2024 | $0 |
| 2024 | 2024 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01NS136624 | Role of the TE-cGAS-STING pathway in C9orf72-ALS/FTD pathogenesis | 000 | 1 | NIH | 9/17/2024 | $697,907 |
| 2024 | 2024 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R18HS030060 | Systems Engineering for Ransomware Attack Response Resiliency in Radiation Oncology | 000 | 1 | AHRQ | 7/29/2024 | $393,974 |
| 2024 | 2024 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | T32GM144302 | Training Grant in Cellular, Biochemical and Molecular Sciences | 000 | 3 | NIH | 8/13/2024 | $439,487 |
| 2024 | 2024 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01CA268899 | A novel strategy for transcriptional reprogramming of lymphoid leukemia cells | 001 | 3 | NIH | 4/18/2024 | $27,067 |
| 2024 | 2024 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01CA238241 | Microbubble Cavitation for Improving Hepatocellular Carcinoma Radioembolization | 000 | 5 | NIH | 11/14/2023 | $302,610 |
| 2024 | 2024 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01DK138011 | Relevance of fatty acid handling in the adaptive response to mitochondrial dysfunction | 000 | 1 | NIH | 2/26/2024 | $542,156 |
| 2024 | 2024 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | F30NS125921 | Parkinson's disease therapies targeting GUCY2C | 000 | 3 | NIH | 8/6/2024 | $53,974 |
| 2024 | 2024 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01DK129462 | Mechanisms of contractile dysfunction in the obstructed bladder: Role of desmin and vimentin | 000 | 3 | NIH | 8/7/2024 | $372,179 |
| 2024 | 2024 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | A2233093 | Nurse Anesthetist Traineeships | 01 | 6 | HRSA | 7/30/2024 | $0 |
| 2024 | 2024 | THOMAS JEFFERSON UNIVERSITY | 833 Chestnut St | Philadelphia | PA | 19107-4427 | PHILADELPHIA | USA | A2233093 | Nurse Anesthetist Traineeships | 00 | 6 | HRSA | 5/24/2024 | $5,518 |
| 2024 | 2024 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01CA268899 | A novel strategy for transcriptional reprogramming of lymphoid leukemia cells | 000 | 3 | NIH | 12/22/2023 | $487,186 |
| 2024 | 2024 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01CA284017 | Deciphering the role of NELFE in modulating MYC signaling in HCC | 000 | 2 | NIH | 6/7/2024 | $337,674 |
| 2024 | 2024 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R21HD115868 | Assessment of placenta vascularization development using contrast-enhanced ultrasound | 000 | 1 | NIH | 9/13/2024 | $429,000 |
| 2024 | 2024 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R21HD114095 | Assessment of Uterine Cervical Insufficiency using 4D Contrast-Enhanced Ultrasound | 000 | 1 | NIH | 9/13/2024 | $429,000 |
| 2024 | 2024 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01NS134987 | Neuroimaging and Connectome Analysis as a Diagnostic and Prognostic Biomarker of SCI Induced Neuropathic Pain | 000 | 1 | NIH | 12/27/2023 | $576,683 |
| 2024 | 2024 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R35GM150811 | Elucidating the roles for discrete actin filaments in maintenance of organelle and cellular homeostasis | 000 | 2 | NIH | 7/12/2024 | $390,000 |
| 2024 | 2024 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01HL175371 | Role of tRNA- and rRNA-derived RNAs in acute lung injury | 000 | 1 | NIH | 9/1/2024 | $626,956 |
|